Patients in England with head and neck cancer will be fast-tracked onto a clinical trial for a "potentially transformative" new vaccine, under an initiative announced by the NHS.
The first patients have received the jab, which uses mRNA technology to train the immune system to fight cancerous cells, with more set to be enrolled at their nearest NHS hospital.